Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
5(36%)
Results Posted
40%(2 trials)
Terminated
1(7%)

Phase Distribution

Ph early_phase_1
1
7%
Ph phase_1
4
29%
Ph phase_2
2
14%
Ph not_applicable
5
36%

Phase Distribution

5

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 1Safety & dosage
4(33.3%)
Phase 2Efficacy & side effects
2(16.7%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

5

trials recruiting

Total Trials

14

all time

Status Distribution
Active(5)
Completed(5)
Terminated(3)
Other(1)

Detailed Status

Completed5
Recruiting3
Withdrawn2
Active, not recruiting2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
5
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (8.3%)
Phase 14 (33.3%)
Phase 22 (16.7%)
N/A5 (41.7%)

Trials by Status

completed536%
terminated17%
withdrawn214%
unknown17%
recruiting321%
active_not_recruiting214%

Recent Activity

5 active trials
Showing 5 of 14
active_not_recruitingearly_phase_1

Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders

NCT02790853
recruitingphase_1

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

NCT03384238
active_not_recruitingnot_applicable

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

NCT00542373
completedphase_1

Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

NCT05808140
recruitingphase_1

Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer

NCT05945875
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT02790853Early Phase 1

Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders

Active Not Recruiting
NCT03384238Phase 1

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Recruiting
NCT00542373Not Applicable

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Active Not Recruiting
NCT05808140Phase 1

Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

Completed
NCT05945875Phase 1

Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer

Recruiting
NCT03938701Phase 2

Fluorescence Imaging of IBD and RA Using Adalimumab-800CW

Recruiting
NCT03033225Phase 2

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

Completed
NCT01816841Not Applicable

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

Completed
NCT02315092

Evaluation of Fluorescence-image Guided Wound Assessment vs. Standard Practice

Completed
NCT00873366

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Terminated
NCT01281488Phase 1

Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors

Completed
NCT02669485Not Applicable

The Impact of Indocyanine Green-enhanced Fluorescence Imaging on Bowel Transection in Left-sided Colorectal Resection

Unknown
NCT01104389Not Applicable

Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging

Withdrawn
NCT01688414Not Applicable

Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer

Withdrawn

All 14 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
14